This inventor holds 1 USPTO granted patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Edward J Beattie, Jr: Innovator in Cancer Research
Introduction
Edward J Beattie, Jr. is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly through his innovative work on human monoclonal antibodies.
Latest Patents
Edward J Beattie, Jr. holds a patent for "Human monoclonal antibodies to cancer cells." This patent discloses hybridomas that produce human monoclonal antibodies. The hybridomas are formed by fusing lymphocytes from individuals with various cancers to an immortal cell line, such as a myeloma, from either a human or a mouse cell line. He has 1 patent to his name.
Career Highlights
Beattie is affiliated with the Sloan-Kettering Institute for Cancer Research, where he continues to advance the understanding and treatment of cancer through his research and innovations.
Collaborations
Some of his notable coworkers include Richard J Cote and Donna M Morrissey, who have also contributed to the field of cancer research.
Conclusion
Edward J Beattie, Jr. exemplifies the spirit of innovation in cancer research, making strides that could potentially lead to significant advancements in treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile